Research

Hormonal

In patients with Type 2 Diabetes and a CAC score of 0 (very low risk), de-escalating multifactorial treatment targets (e.g., less intensive lipid and blood pressure management) is non-inferior to standard treatment regarding cardiovascular events.

If you have Type 2 Diabetes but a Coronary Artery Calcification (CAC) score of 0, your risk of a cardiovascular event is very low (about 1% over 5 years). This trial investigates whether it is safe to reduce the intensity of your cholesterol and blood pressure medications compared to standard care. If your CAC is 0, you might be able to simplify your medication regimen with your doctor, focusing on glucose control and avoiding side effects, without significantly increasing your heart risk.

WeakQualifiesMEDIUM confidence
We hypothesise that downgraded multifactorial treatment is non- inferior to standard treatment in patients with CAC score of zero.
Kristian Løkke Funck et al. · BMJ Open · 2025

Why this rating

This is a study protocol; results are pending.

Source

Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?

Kristian Løkke Funck et al. · BMJ Open · 2025

DOI 10.1136/bmjopen-2025-106018

rct · n=7300
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →